Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa

CONTEXT: The role of somatostatin analogues (SSTa) in the treatment of acromegaly. OBJECTIVE: To evaluate the antihormonal and antitumour efficacy of long-term (up to 18 years) primary treatment with SSTa in patients with GH-secreting pituitary adenoma responsive to SSTa. DESIGN: An open, prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiza, Jean Christophe, Vezzosi, Delphine, Matta, Maria, Donadille, Florence, Loubes-Lacroix, Florence, Cournot, Maxime, Bennet, Antoine, Caron, Philippe
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974833/
https://www.ncbi.nlm.nih.gov/pubmed/17524029
http://dx.doi.org/10.1111/j.1365-2265.2007.02878.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974833/
https://www.ncbi.nlm.nih.gov/pubmed/17524029
http://dx.doi.org/10.1111/j.1365-2265.2007.02878.x

Ejemplares similares